Subscribe

Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn't arrive within 3 minutes, check your spam folder.

Ok, Thanks
Biotech Health Tech

Indian biotech startup Immuneel Therapeutics raises $15 million in Series A

Immuneel Therapeutics, an India-based biotech firm developing cell and gene therapies has raised $15 million in its Series A funding round co-led by Eight Road Ventures, True North, and F-Prime Capital. * The firm is working on developing its own pipeline of chimeric antigen receptor T-Cell (CAR-T) therapies and other cellular

Oluwajuwonlo Afolabi profile image
by Oluwajuwonlo Afolabi
Updated
Indian biotech startup Immuneel Therapeutics raises $15 million in Series A
Photo by National Cancer Institute / Unsplash

Immuneel Therapeutics, an India-based biotech firm developing cell and gene therapies has raised $15 million in its Series A funding round co-led by Eight Road Ventures, True North, and F-Prime Capital.

  • The firm is working on developing its own pipeline of chimeric antigen receptor T-Cell (CAR-T) therapies and other cellular immunotherapies for management and treatment of cancer.
  • The fund will be used to support the development of the pipeline and its improvement.
  • It last raised $15 million from UHNI, a VC firm based in the US.
Oluwajuwonlo Afolabi profile image
by Oluwajuwonlo Afolabi
Updated

Subscribe to Techloy.com

Get the latest information about companies, products, careers, and funding in the technology industry across emerging markets globally.

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Read More